Efficacy of a combination of idarubicin, etoposide and intermediate-dose cytosine arabinoside as salvage therapy in relapsing or resistant unfavorable lymphoma.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Francesco Passamonti |
| Publication date | April 1, 1998 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |